[Federal Register Volume 91, Number 161 (Friday, August 21, 2026)]
[Notices]
[Pages 54408-54409]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-17161]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on September 9, 2026, to discuss and provide recommendations
from the subcommittee on reducing barriers to medical use licensing
rulemaking. Topic is tentative based on its rulemaking schedule.
Meeting information, including a copy of the agenda and handouts, will
be available on the ACMUI's Meetings and Related Documents web page at
https://www.nrc.gov/reading-rm/doc-
[[Page 54409]]
collections/acmui/meetings/2026 or by emailing Ms. Sarah Hoenig at the
contact information below.
DATES:
Date and Time for Open Session: September 9, 2026, from 1:00 p.m.
to 3:00 p.m. EST.
------------------------------------------------------------------------
Webinar information (Microsoft
Date Teams)
------------------------------------------------------------------------
September 9, 2026................. Link: https://teams.microsoft.com/meet/246083786721656?p=lzF9cElF5raCITSY0O O.
Meeting ID: 246 083 786 721 656.
Passcode: WC9Ac6cH.
Call in number (audio only): +1 301-
576-2978, United States, Silver
Spring.
Phone conference ID: 969 086 535 #.
------------------------------------------------------------------------
Public Participation: Any member of the public who wishes to
participate in the meeting via Microsoft Teams or via phone should
contact Ms. Sarah Hoenig using the information below.
FOR FURTHER INFORMATION CONTACT: Ms. Sarah Hoenig, email:
[email protected] phone: 301-415-3284.
SUPPLEMENTARY INFORMATION:
Purpose: Discuss recommendations from the subcommittee on reducing
barriers to medical use licensing rulemaking.
Conduct of the Meeting
The ACMUI Chair, Hossein Jadvar, M.D., Ph.D., will preside over the
meeting. Dr. Jadvar will conduct the meeting in a manner that will
facilitate the orderly conduct of business. The following procedures
apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Sarah Hoenig using the contact information
listed above. All submittals must be received by the close of business
on September 4, 2026, and must only pertain to the topics on the
agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2026 on or about October 9, 2026.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Sarah Hoenig of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland, this 19 day of August 2026.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2026-17161 Filed 8-20-26; 8:45 am]
BILLING CODE 7590-01-P